Intellectual Property India Publishes Patent Application for 'Prodrugs Of 4'-Substituted Nucleoside Reverse Transcriptase Inhibitors' Filed by Merck Sharp & Dohme Llc

MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517079406 A) filed by Merck Sharp & Dohme Llc, Rahway, U.S.A., on Aug. 21, for 'prodrugs of 4'-substituted nucleoside reverse transcriptase inhibitors.'

Inventor(s) include Embrey, Mark W.; Layton, Mark E; Raheem, Izzat T.; and Grobler, Jay A.

The application for the patent was published on Sept. 12, under issue no. 37/2025.

According to the abstract released by the Intellectual Property India: "The present invention is directed to prodrugs of compound A: which are nucleoside reverse transcriptase translocation inhibitors (NRTTI) and are useful in the inhibition of HIV reverse transcriptase. The present invention also relates to the use of these...